Ciclesonide (Oral Inhalation) and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Ciclesonide (Oral Inhalation) and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ciclesonide
Brand name: Alvesco HFA, Alvesco
Synonyms: Ciclesonide (inhalation)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ciclesonide (Oral Inhalation)-Insulin degludec
- Ciclesonide (Oral Inhalation)-Insulin Degludec (U-100) Prefilled Pens
- Ciclesonide (Oral Inhalation)-Insulin Degludec (U-100) Vials
- Ciclesonide (Oral Inhalation)-Insulin Degludec (U-200) Prefilled Pens
- Ciclesonide (Oral Inhalation)-Insulin degludec and liraglutide
- Ciclesonide (Oral Inhalation)-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Ciclesonide (Systemic, Oral Inhalation)
- Insulin aspart, recombinant Subcutaneous-Ciclesonide eent
- Insulin aspart, recombinant Subcutaneous-Ciclesonide inhalation
- Insulin aspart, recombinant Subcutaneous-Ciclesonide nasal
- Insulin aspart, recombinant Subcutaneous-Ciclesonide Nasal Aerosol
- Insulin aspart, recombinant Subcutaneous-Ciclesonide Nasal Spray